PDS Biotechnology
PDSB
PDSB
43 hedge funds and large institutions have $6.07M invested in PDS Biotechnology in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.56M | |
| 2 | +$95.9K | |
| 3 | +$46.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.7K |
| 5 |
Bank of New York Mellon
New York
|
+$36.1K |
Top Sellers
| 1 | -$390K | |
| 2 | -$148K | |
| 3 | -$89.4K | |
| 4 |
Squarepoint
New York
|
-$89.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JWBC
51
J.W. Burns & Co
Dewitt,
New York
| – |
|
|||
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| – |
|
|||
53
Fidelity Investments
Boston,
Massachusetts
| – |
|
|||
|
RWM
54
Rialto Wealth Management
Syracuse,
New York
| – |
|